Back to companies

Pharming Group NV: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Pharming Group NV (Pharming) develops precision medicines and innovative protein replacement therapies for the treatment of rare diseases and unmet medical needs. The company’s marketed product includes, Ruconest (conestat alfa), a recombinant human C1 inhibitor is used for the treatment of acute hereditary angioedema (HAE) and has been approved in the US, the UK, Europe, Israel, and South Korea. Its product pipeline consists of rhC1INH for the treatment of pre-eclampsia, COVID-19 and acute kidney injury; leniolisib for treatment of activated phosphoinositide 3-kinase delta syndrome (APDS); α-Glucosidase for the treatment of pompe and fabry’s disease. The company markets its products through own sales force and network of distributors and partners. Pharming is headquartered in Leiden, the Netherlands.

Headquarters Netherlands

Address Darwinweg 24, Leiden, 2333CR


Telephone 31 71 5247400

No of Employees 321

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange PHARM (AMS)

Revenue (2021) $198.9M -9.7% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX -59.2% (2021 vs 2020)

Market Cap* $528.5M

Net Profit Margin (2021) XXX -54.8% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

40+

Clinical Trials

Determine Pharming Group NV go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Pharming Group NV’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

17+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Pharming Group NV’s relevant decision makers and contact details.

12+

Pipeline Drugs

Identify which of Pharming Group NV’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

4

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

Sales & Consensus Forecasts

Understand the current and future drug revenue for Pharming Group NV and assess market opportunity for new entrants with patient population 8-year forecasts.

2

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

1

Marketed Drugs

Understand Pharming Group NV’s commercialized product portfolio to stay one step ahead of the market.

1

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Ruconest- Acute Hereditary Angioedema (HAE) Ruconest
Pipeline
rhC1INH- Pre-Eclampsia, COVID-19 and Acute Kidney Injury
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2021 Contracts/Agreements In December, the company renewed its manufacturing partnership with Sanofi SA.
2021 Contracts/Agreements In July, the company and NewBridge Pharmaceuticals signed a licence agreement for the distribution of RUCONEST in the Middle East and North Africa.
2021 Contracts/Agreements In July, the company entered into a strategic collaboration with Orchard Therapeutics to research, develop, manufacture and commercialize OTL-105 for the treatment of hereditary angioedema.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Pharming Group NV Galapagos NV Argenx SE Lannett Co Inc Crucell NV (Inactive)
Headquarters Netherlands Belgium Netherlands United States of America Netherlands
City Leiden Malines (Mechelen) Breda Trevose Leiden
State/Province - - - Pennsylvania Zuid-Holland
No. of Employees 321 1,305 650 812 -
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Net Income Growth

Image for loader
Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Paul Sekhri Chairman Executive Board 2008 63
Sijmen De Vries, M.D. Director; Chief Executive Officer Executive Board 2016 61
Jeroen Wakkerman Chief Financial Officer Senior Management 2020 51
Mireille Sanders Chief Operating Officer Senior Management 2020 53
Anurag Relan Chief Medical Officer Senior Management 2021 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer